These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 37720221)

  • 21. Immunotherapy as a Promising Option for the Treatment of Advanced Chordoma: A Systemic Review.
    Wang X; Chen Z; Li B; Fan J; Xu W; Xiao J
    Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612259
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advantages of targeting the tumor immune microenvironment over blocking immune checkpoint in cancer immunotherapy.
    Tang T; Huang X; Zhang G; Hong Z; Bai X; Liang T
    Signal Transduct Target Ther; 2021 Feb; 6(1):72. PubMed ID: 33608497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Defective HLA Class I Expression and Patterns of Lymphocyte Infiltration in Chordoma Tumors.
    Patel SS; Nota SP; Sabbatino F; Nielsen GP; Deshpande V; Wang X; Ferrone S; Schwab JH
    Clin Orthop Relat Res; 2021 Jun; 479(6):1373-1382. PubMed ID: 33273248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comprehensive Analysis of the Tumor Immune Microenvironment Landscape in Glioblastoma Reveals Tumor Heterogeneity and Implications for Prognosis and Immunotherapy.
    Zhao R; Pan Z; Li B; Zhao S; Zhang S; Qi Y; Qiu J; Gao Z; Fan Y; Guo Q; Qiu W; Wang S; Wang Q; Zhang P; Guo X; Deng L; Xue H; Li G
    Front Immunol; 2022; 13():820673. PubMed ID: 35309323
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of radiotherapy in the age of immunotherapy.
    Sato H; Demaria S; Ohno T
    Jpn J Clin Oncol; 2021 Apr; 51(4):513-522. PubMed ID: 33561212
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chordoma and chondrosarcoma gene profile: implications for immunotherapy.
    Schwab JH; Boland PJ; Agaram NP; Socci ND; Guo T; O'Toole GC; Wang X; Ostroumov E; Hunter CJ; Block JA; Doty S; Ferrone S; Healey JH; Antonescu CR
    Cancer Immunol Immunother; 2009 Mar; 58(3):339-49. PubMed ID: 18641983
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune Myocarditis Overlapping With Myasthenia Gravis Due to Anti-PD-1 Treatment for a Chordoma Patient: A Case Report and Literature Review.
    Liang S; Yang J; Lin Y; Li T; Zhao W; Zhao J; Dong C
    Front Immunol; 2021; 12():682262. PubMed ID: 34305915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current insights into the hepatic microenvironment and advances in immunotherapy for hepatocellular carcinoma.
    Zhao M; Huang H; He F; Fu X
    Front Immunol; 2023; 14():1188277. PubMed ID: 37275909
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination immunotherapy for pancreatic cancer: challenges and future considerations.
    Gössling GCL; Zhen DB; Pillarisetty VG; Chiorean EG
    Expert Rev Clin Immunol; 2022 Nov; 18(11):1173-1186. PubMed ID: 36045547
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel strategies for cancer immunotherapy: counter-immunoediting therapy.
    Liu S; Sun Q; Ren X
    J Hematol Oncol; 2023 Apr; 16(1):38. PubMed ID: 37055849
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of the tumor immune microenvironment in tumor immunotherapy.
    Zhou C; Liu Q; Xiang Y; Gou X; Li W
    Oncol Lett; 2022 Feb; 23(2):53. PubMed ID: 34992685
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunotherapy of hepatocellular carcinoma: recent progress and new strategy.
    Li J; Xuan S; Dong P; Xiang Z; Gao C; Li M; Huang L; Wu J
    Front Immunol; 2023; 14():1192506. PubMed ID: 37234162
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Making "cold" tumors "hot"- radiotherapy remodels the tumor immune microenvironment of pancreatic cancer to benefit from immunotherapy: a case report.
    Tong F; Sun Y; Zhu Y; Sha H; Ni J; Qi L; Gu Q; Zhu C; Xi W; Liu B; Kong W; Du J
    Front Immunol; 2023; 14():1277810. PubMed ID: 38179049
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune microenvironment of cholangiocarcinoma: Biological concepts and treatment strategies.
    Yu X; Zhu L; Wang T; Chen J
    Front Immunol; 2023; 14():1037945. PubMed ID: 37138880
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acquired resistance for immune checkpoint inhibitors in cancer immunotherapy: challenges and prospects.
    Chen X; Zhang W; Yang W; Zhou M; Liu F
    Aging (Albany NY); 2022 Jan; 14(2):1048-1064. PubMed ID: 35037899
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Role of the Tumor Microenvironment and Treatment Strategies in Colorectal Cancer.
    Chen Y; Zheng X; Wu C
    Front Immunol; 2021; 12():792691. PubMed ID: 34925375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mild hyperthermia promotes immune checkpoint blockade-based immunotherapy against metastatic pancreatic cancer using size-adjustable nanoparticles.
    Yu Q; Tang X; Zhao W; Qiu Y; He J; Wan D; Li J; Wang X; He X; Liu Y; Li M; Zhang Z; He Q
    Acta Biomater; 2021 Oct; 133():244-256. PubMed ID: 34000465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor microenvironment-mediated immune tolerance in development and treatment of gastric cancer.
    Liu Y; Li C; Lu Y; Liu C; Yang W
    Front Immunol; 2022; 13():1016817. PubMed ID: 36341377
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Strategies to Improve the Antitumor Effect of Immunotherapy for Hepatocellular Carcinoma.
    Xing R; Gao J; Cui Q; Wang Q
    Front Immunol; 2021; 12():783236. PubMed ID: 34899747
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emerging immune checkpoints in the tumor microenvironment: Implications for cancer immunotherapy.
    Wei G; Zhang H; Zhao H; Wang J; Wu N; Li L; Wu J; Zhang D
    Cancer Lett; 2021 Jul; 511():68-76. PubMed ID: 33957184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.